Log In
BCIQ
Print this Print this
 

Integrin alpha(4) (VLA-4 ) (CD49D)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Integrin alpha(4) (VLA-4 ) (CD49D)

BCIQ
Print ChartPrint this
1 - Autoimmune 1 - Neurology 2 - Autoimmune
Phase of DevelopmentPhase IIMarketed
Autoimmune

2

1

Neurology

1

-




 Products Targeting Integrin alpha(4) (VLA-4 ) (CD49D)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$20,387.7M

$6,481.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today